TTC17 and breast cancer: To determine whether TTC17 affects the response of BC cells to antineoplastic drugs, we screened an anticancer drug library consisting of 313 commercially available drugs in control and TTC17-knockdown MDA-MB-231 cells (Fig. 6a, b).